SCHEMBL7612240

SCHEMBL7612240

O=C(Nc1nnc(C(F)(F)Cl)s1)c1c(O)c2ccc(F)cc2oc1=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 4/20 0.46
▸ MEN1 O00255 3/20 0.46
▸ NQO1 P15559 1/20 0.41
▸ TAS1R3 Q7RTX0 1/20 0.40
▸ TAS1R1 Q7RTX1 1/20 0.40
▸ TAS1R2 Q8TE23 1/20 0.40
▸ NPC1 O15118 5/20 0.40
▸ HTT P42858 4/20 0.40
▸ RAB9A P51151 4/20 0.40
▸ POLB P06746 2/20 0.38
▸ RXFP1 Q9HBX9 2/20 0.38
▸ PRNP P04156 1/20 0.38
▸ MAPT P10636 2/20 0.37
▸ HPGD P15428 2/20 0.37
▸ LMNA P02545 2/20 0.36
▸ SMN1; SMN2 Q16637 3/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ CASP3 P42574 1/20 0.36
▸ SENP8 Q96LD8 1/20 0.36
▸ SENP7 Q9BQF6 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7610155 0.92 MEN1 (0.56) KMT2AMEN1NQO1TAS1R3TAS1R1
SCHEMBL7613159 0.90 MEN1 (0.43) KMT2AMEN1TAS1R3TAS1R1TAS1R2
SCHEMBL9208422 0.90 MEN1 (0.46) KMT2AMEN1NQO1TAS1R3TAS1R1
SCHEMBL7620367 0.89 KMT2A (0.45) KMT2AMEN1TAS1R3TAS1R1TAS1R2
SCHEMBL7613080 0.89 KMT2A (0.43) KMT2AMEN1TAS1R3TAS1R1TAS1R2
SCHEMBL7610344 0.84 MEN1 (0.56) KMT2AMEN1NQO1TAS1R3TAS1R1
SCHEMBL7620350 0.83 CA12 (0.49) KMT2AMEN1TAS1R3TAS1R1TAS1R2
SCHEMBL7618641 0.83 MEN1 (0.52) KMT2AMEN1TAS1R3TAS1R1TAS1R2
SCHEMBL7617104 0.82 KMT2A (0.53) KMT2AMEN1TAS1R3TAS1R1TAS1R2
SCHEMBL7620353 0.82 NQO1 (0.43) KMT2AMEN1NQO1NPC1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0869785-B1 4-HYDROXYCOUMARIN-3-CARBOXAMIDES FOR THE TREATMENT OF NON-INSULIN DEPENDENT DIABETES MELLITUS UPJOHN CO (US) 2002-08-28 — — EP claimed
Send feedback